NCT05029115View on ClinicalTrials.gov

The Effect of SGLT-2 Inhibitor in Patient With Atrial Fibrillation and Diabetes Mellitus

Enrolling by invitationOBSERVATIONAL
Enrollment

716

Participants

Timeline

Start Date

October 5, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
SGLT-2 InhibitorAtrial FibrillationDiabetes Mellitus, Type 2
Interventions
DRUG

SGLT2 inhibitor

Dapagliflozin, Empagliflozin

Trial Locations (1)

07985

Ewha womans university mokdong hospital, Yangcheon

All Listed Sponsors
lead

Ewha Womans University Mokdong Hospital

OTHER

NCT05029115 - The Effect of SGLT-2 Inhibitor in Patient With Atrial Fibrillation and Diabetes Mellitus | Biotech Hunter | Biotech Hunter